Serotonin function following remission from bulimia nervosa

Neuropsychopharmacology

Volumn 22, Issue 3, 2000, Pages 257-263

  Wolfe, Barbara E ^a   Metzger, Eran D ^a   Levine, Jeffrey M ^b   Finkelstein, Dianne M ^c   Cooper, Thomas B ^d,e   Jimerson, David C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Bulimia nervosa; Eating disorders; Neuroendocrine; Serotonin

Indexed keywords

FENFLURAMINE; PLACEBO; PROLACTIN; SEROTONIN; SEROTONIN AGONIST;

ARTICLE; BINGE EATING DISORDER; BULIMIA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HUMAN; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; REMISSION; SEROTONINERGIC SYSTEM;

ADULT; AMINO ACIDS; BULIMIA; FEMALE; FENFLURAMINE; HORMONES; HUMANS; PLACEBOS; PROLACTIN; REFERENCE VALUES; SEROTONIN; SEROTONIN AGONISTS; TRYPTOPHAN;

EID: 0033968811     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00117-7     Document Type: Article

References (48)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, Revised:1987;American Psychiatric Press, Washington DC.
2. Anderson I.M., Crook W.S., Gartside S.E., Parry-Billings M., Newsholme E.A., Cowen P.J. Effect of moderate weight loss on prolactin secretion in normal volunteers. Psychiatry Res. 29:1989;161-167.
3. Beck A.T., Steer R.T. Beck Depression Inventory Manual. 1987;Psychological Corporation Harcourt Brace Jovanovich, New York, NY.
4. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226.
5. Blundell J.E., Hill A.J. Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. Int J Obes. 11(Suppl 3):1987;141-155.
6. Brewerton T.D., Mueller E.A., Lesem M.D., Brandt H.A., Quearry B., George D.T., Murphy D.L., Jimerson D.C. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Arch Gen Psychiatry. 49:1992;852-861.
7. Cleare A.J., McGregor A., O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clin Endocrinol. 43:1995;713-719.
8. Coccaro E.F., Kavoussi R.J., Cooper T.B., Hauger R.L. Central serotonin activity and aggression. Inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects Am J Psychiatry. 154:1997;1430-1435.
9. Cowen P.J. Serotonin receptor subtypes in depression. Evidence from studies in neuroendocrine regulation Clin Neuropharmacol. 16:1993;S6-S18.
10. Denckla W.D., Dewey H.K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 69:1967;160-169.
11. Durnin J.V.G.A., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness. Measurements on 481 men and women aged from 16 to 72 years Br J Nutr. 32:1974;77-97.
12. Endicott J., Spitzer R.L. A diagnostic interview. The schedule for affective disorders and schizophrenia Arch Gen Psychiatry. 35:1978;837-844.
13. Fernandes C., McKittrick C.R., File S.E., McEwen B.S. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology. 22:1997;477-491.
14. Garattini S., Mennini T., Bendotti C., Invernizzi R., Samanin R. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite. 7(Suppl):1986;15-38.
15. Garner D.M., Olmsted M.P., Bohr Y., Garfinkel P.E. The Eating Attitudes Test. Psychometric features and clinical correlates Psychol Med. 12:1982;871-878.
16. Goldbloom D.S., Garfinkel P.E., Katz R., Brown G.M. The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa. J Psychosom Res. 40:1996;289-297.
17. Goodall E., Silverstone T. Differential effect of d-fenfluramine and metergoline on food intake in human subjects. Appetite. 11:1988;215-228.
18. Halmi K.A., McBride P.A., Sunday S.R. Serotonin responsivity and hunger and satiety in eating disorders. Adv Biosci. 90:1993;123-131.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
20. Jimerson D.C., Lesem M.D., Kaye W.H., Brewerton T.D. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry. 49:1992;132-138.
21. Jimerson D.C., Lesem M.D., Kaye W.H., Hegg A.P., Brewerton T.D. Eating disorders and depression. Is there a serotonin connection? Biol Psychiatry. 28:1990;443-454.
22. Jimerson D.C., Wolfe B.E., Brotman A., Metzger E.D. Medications in the treatment of eating disorders. Psychiatry Clin North Am. 19:1996;739-754.
23. Jimerson D.C., Wolfe B.E., Metzger E.D., Finkelstein D.M., Cooper T.B., Levine J.M. Decreased serotonin function in bulimia nervosa. Arch Gen Psychiatry. 54:1997;529-534.
24. Kaye W.H., Greeno C.G., Moss H., Fernstrom J., Fernstrom M., Lilenfeld L.R., Weltzin T.E., Mann J.J. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry. 55:1998;927-935.
25. Kissileff H.R., Wentzlaff T.H., Guss J.L., Walsh B.T., Devlin M.J., Thornton J.C. A direct measure of satiety disturbance in patients with bulimia nervosa. Physiol Behav. 60:1996;1077-1085.
26. Krebs H.A., Cheng L.K., Wright G.J. Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromat. 310:1984;412-417.
27. LaChaussee J.L., Kissileff H.R., Walsh B.T., Hadigan C.M. The single-item meal as a measure of binge-eating behavior in patients with bulimia nervosa. Physiol Behav. 51:1992;593-600.
28. Leibowitz S.F., Weiss G.F., Suh J.S. Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior. Pharmacol Biochem Behav. 37:1990;735-742.
29. Levitan R.D., Kaplan A.S., Joffe R.T., Levitt A.J., Brown G.M. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry. 54:1997;521-527.
30. Levy A.B., Dixon K.N., Malarkey W.B. Pituitary response to TRH in bulimia. Biol Psychiatry. 23:1988;476-484.
31. Lohman T.G., Roche A.F., Martorell R. Anthropometric Standardization Reference Manual. 1st ed:1988;Human Kinetics Books, Champaign, IL.
32. Mitchell J.E., Laine D.C. Monitored binge-eating behavior in patients with bulimia. Int J Eat Disord. 4:1985;177-183.
33. Monteleone P., Brambilla F., Bortolotti F., Ferraro C., Maj M. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes. Psychol Med. 28:1998;975-983.
34. Obarzanek E., Lesem M.D., Goldstein D.S., Jimerson D.C. Reduced resting metabolic rate in patients with bulimia nervosa. Arch Gen Psychiatry. 48:1991;456-462.
35. Oldman A.D., Walsh A.E.S., Salkovskis P., Fairburn C.G., Cowen P.J. Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects. A pilot study Psychol Med. 25:1995;995-1001.
36. Olmsted M.P., Kaplan A.S., Rockert W. Rate and prediction of relapse in bulimia nervosa. Am J Psychiatry. 151:1994;738-743.
37. Pirke K.M., Pahl J., Schweiger U., Warnhoff M. Metabolic and endocrine indices of starvation in bulimia. A comparison with anorexia nervosa Psychiatry Res. 15:1985;33-39.
38. Smith K.A., Fairburn C.G., Cowen P.J. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry. 56:1999;171-176.
39. Build Study, 1979. 1980;Society of Actuaries, Chicago.
40. Spielberger C.D. Manual for the State-Trait Anxiety Inventory (STAI-Form-Y). 1983;Consulting Psychologist Press, Palo Alto, CA.
41. Spitzer R.L., Endicott J., Robins E. Research diagnostic criteria. Rationale and reliability Arch Gen Psychiatry. 35:1978;773-782.
42. ® 9.0 [Computer Software] (1999): Chicago, IL, SPSS Inc.
43. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 374:1995;542-546.
44. Weltzin T.E., Fernstrom M.H., Fernstrom J.D., Neuberger S.K., Kaye W.H. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am J Psychiatry. 152:1995;1668-1671.
45. Weltzin T.E., McConaha C., McKee M., Hsu L.K.G., Perel J., Kaye W.H. Circadian patterns of cortisol, prolactin, and growth hormone secretion during binging and vomiting in normal weight bulimic patients. Biol Psychiatry. 30:1991;37-48.
46. Wolfe B.E., Jimerson D.C., Levine J.M. Impulsivity ratings in bulimia. relationship to binge eating behaviors Int J Eat Disord. 15:1994;289-292. a.
47. Wolfe B.E., Jimerson D.C., Metzger E.D., Levine J.M. Serotonergic challenge responses in women with a history of bulimia nervosa. Biol Psychiatry. 35:1994;736-737. b [Abst].
48. Wolfe B.E., Metzger E.D., Jimerson D.C. Research update on serotonin function in bulimia nervosa and anorexia nervosa. Psychopharmacol Bull. 33:1997;345-354.